- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 33/10 - Anthelmintics
Patent holdings for IPC class A61P 33/10
Total number of patents in this class: 479
10-year publication summary
|
20
|
20
|
19
|
27
|
44
|
35
|
42
|
30
|
34
|
16
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Intervet International B.V. | 1289 |
28 |
| Bayer Animal Health GmbH | 221 |
24 |
| Elanco Tiergesundheit AG | 415 |
22 |
| Intervet Inc. | 909 |
17 |
| Nihon Nohyaku Co., Ltd. | 326 |
16 |
| Elanco Animal Health GmbH | 327 |
16 |
| Nippon Soda Co., Ltd. | 893 |
14 |
| Boehringer Ingelheim Animal Health USA Inc. | 420 |
13 |
| University of Massachusetts | 2228 |
12 |
| The Governing Council of The University of Toronto, | 1478 |
11 |
| Boehringer Ingelheim Vetmedica GmbH | 1270 |
10 |
| CEVA Sante Animale | 697 |
9 |
| Sumitomo Chemical Company, Limited | 9049 |
8 |
| Zoetis LLC | 46 |
7 |
| Celgene Corporation | 1396 |
6 |
| The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. | 368 |
5 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2856 |
5 |
| The University of Tokyo | 4182 |
5 |
| Bomac Research Limited | 14 |
5 |
| Boehringer Ingelheim Pharma GmbH & Co. Kg | 553 |
4 |
| Other owners | 242 |